M. Ramaswamy

K. Wasan, P. Pritchard, M. Ramaswamy, 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Rat and Rabbit Plasma Distribution of Free and Chylomicron-Associated BIRT 377, a Novel Small Molecule Antagonist of LFA-1-Mediated Cell Adhesion

K. Wasan, D. Hauss, M. Ramaswamy, 2001, Pharmaceutical Research.

Amphotericin B Lipid Complex or Amphotericin B Multiple-Dose Administration to Rabbits with Elevated Plasma Cholesterol Levels: Pharmacokinetics in Plasma and Blood, Plasma Lipoprotein Levels, Distribution in Tissues, and Renal Toxicities

K. Wasan, M. Ramaswamy, K. Peteherych, 2001, Antimicrobial Agents and Chemotherapy.

Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers.

H. Burt, K. Wasan, M. Ramaswamy, 1997, Journal of pharmaceutical sciences.

The Stereoselective Distribution of Halofantrine Enantiomers Within Human, Dog, and Rat Plasma Lipoproteins

D. Brocks, K. Wasan, M. Ramaswamy, 2000, Pharmaceutical Research.

Species Differences in the Proportion of Plasma Lipoprotein Lipid Carried by High-Density Lipoproteins Influence the Distribution of Free and Liposomal Nystatin in Human, Dog, and Rat Plasma

K. Wasan, M. Ramaswamy, P. Cossum, 1999, Antimicrobial Agents and Chemotherapy.

Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma

M. Kazemi, R. Thies, K. Wasan, 1997, Antimicrobial agents and chemotherapy.

Heat Treatment of Amphotericin B Modifies Its Serum Pharmacokinetics, Tissue Distribution, and Renal Toxicity following Administration of a Single Intravenous Dose to Rabbits

K. Wasan, M. Ramaswamy, S. Hartsel, 2001, Antimicrobial Agents and Chemotherapy.

Differences in the Method by Which Plasma Is Separated from Whole Blood Influences Amphotericin B Plasma Recovery and Distribution Following Amphotericin B Lipid Complex Incubation Within Whole Blood

K. Wasan, M. Ramaswamy, 2001, Drug development and industrial pharmacy.

A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells

Sevim Z. Erhan, A. Rauth, J. Manias, 2006, Pharmaceutical Research.

Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer.

K. Wasan, M. Ramaswamy, J. Haley, 1997, Journal of pharmaceutical sciences.

Role of plasma lipoproteins in modifying the toxic effects of water-insoluble drugs: Studies with cyclosporine A

K. Wasan, M. Ramaswamy, M. Kwong, 2008, AAPS PharmSci.

Lipid transfer protein I facilitated transfer of cyclosporine from low- to high-density lipoproteins is only partially dependent on its cholesteryl ester transfer activity.

K. Wasan, P. Pritchard, M. Ramaswamy, 1998, Journal of Pharmacology and Experimental Therapeutics.

Cyclosporine Transfer from Low- and High-Density Lipoproteins Is Partially Influenced by Lipid Transfer Protein I Triglyceride Transfer Activity

K. Wasan, P. Pritchard, M. Ramaswamy, 1999, Pharmaceutical Research.

A Comparison of Step-Gradient and Sequential Density Ultracentrifugation and the Use of Lipoprotein Deficient Plasma Controls in Determining the Plasma Lipoprotein Distribution of Lipid-Associated Nystatin and Cyclosporine

K. Wasan, M. Ramaswamy, S. Cassidy, 2004, Pharmaceutical Research.

Differences in the Lipoprotein Distribution of Free and Liposome-Associated All-trans-Retinoic Acid in Human, Dog, and Rat Plasma Are Due to Variations in Lipoprotein Lipid and Protein Content

J. Ojwang, K. Wasan, M. Ramaswamy, 1998, Antimicrobial Agents and Chemotherapy.